Condition
Epstein-Barr Virus Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Epstein-Barr Virus Infection clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
EBV-targeted T-cell therapy for persistent EBV DNAemia after allogeneic transplant
This treatment will try infusing EBV-specific TCR-engineered T cells into adults with persistent or rising EBV DNA after an allogeneic stem cell transplant to see if the virus clears and the therapy is safe.
-
Vaccination against Epstein-Barr Virus in Healthy Adults
This study is testing two new vaccines for the Epstein-Barr Virus in healthy adults aged 18 to 29 to see if they can safely boost the immune response against the virus.
Related topics
Quick answers
How many Epstein-Barr Virus Infection clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.